What should be the protocol to manage high grade dysplasia in IBD?
Information on authorship and revision
Last modified:
13 March 2013 06:13:35
Author(s):
- Dr William Connell MB BS FRACP — Author
- Professor Michael Kamm MB BS MD FRCP FRACP — Co-author
- Professor James Kench — Co-author
- Dr Rupert W Leong MB BS MD FRACP AGAF — Co-author
- Dr Alissa Walsh MBBS (Hons) FRACP — Co-author
- Cancer Council Australia Surveillance Colonoscopy Guidelines Working Party — Co-author
Contents |
What should be the protocol to manage high grade dysplasia in IBD?
If high grade dysplasia (HGD) is diagnosed in flat mucosa and confirmed by a separate pathologist, surgery is usually required. According to a review of 10 dysplasia studies, a finding of high grade dysplasia was accompanied by actual cancer in 42%, and in the rest who underwent surgery, definite dysplasia was usually detected in colectomy specimens.[1] Experience from the 30 year St Mark’s Hospital surveillance programme found that 19/600 (3.2%) developed HGD. Of these, 11 underwent immediate colectomy and five (45%) had cancer in the operative specimen. Eight patients refused immediate surgery, of whom two subsequently developed CRC. In total, 37% of all patients with HGD eventually developed CRC.[2]
Evidence summary and recommendations
| Evidence summary | Level | References |
|---|---|---|
| The predictive value of HGD for imminent or established cancer is high. | II | [2], [1] |
| Recommendation | Grade |
|---|---|
 High grade dysplasia in flat mucosa is a strong risk factor for established or imminent carcinoma, and colectomy is usually recommended.
|
B |
References
- ↑ 1.0 1.1 Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994 Jan 8;343(8889):71-4 [Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/7903776].
- ↑ 2.0 2.1 Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis Gastroenterology 2006 Apr;130(4):1030-8 [Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/16618396].
Appendices
 View body of evidence
|
 View literature search documentation
|
- Statements regarding the inclusion/exclusion of issues should be clearly supported by scientific evidence, and specifically outline the relevance of the suggested material to the guidelines.
- If you have identified any gaps or errors in the content please suggest suitable text for inclusion.
- Use the blue 'Submit new evidence'-button to submit further/newly published evidence to be considered.
If you create a user account, your comments can be attributed to you and you also get alerts on any replies to your comments.
How to post a public comment
1) Use the blue 'Make a new comment' link below
2) Fill in the empty boxes
3) Press 'save page' to post your comment!